Drugs / RUTI®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02711735 Comparator | Mar → Sep 2020 | multidrug-resistant tuberculosis | Archivel Farma S.L. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RUTI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02711735 ↗ |
| Modality | Vaccine | “RUTI® vaccine” NCT02711735 ↗ |
| Route | Intramuscular | “one single dose of RUTI® vaccine in the right/left deltoid muscle” NCT02711735 ↗ |